Centre belge d'Information Pharmacothérapeutique. - http://www.cbip.be - Consultation du 4 décembre 2010.
Navas EV, Taylor DO. - Can patients with COPD or asthma take a beta-blocker? Cleaveland Clin J Med, 2010, 77, 498-499.
Sin D, Man P. - Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 2003, 107, 1514-1519. (Pubitemid 36378490)
Huiart L, Ernst P, Suissa S. - Cardiovascular morbidity and mortality in COPD. Chest, 2005, 128, 2640-2646.
Curkendall SM, Deluise C, Jones JK, et al. - Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada. Ann Epidemiol, 2006, 16, 63-70. (Pubitemid 41783891)
Calverley PMA, Anderson JA, Celli B, et al. - Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Eng J Med, 2007, 356, 775-789. (Pubitemid 46294610)
Maclay JD, McAllister DA, MacNee W. - Cardiovascular risk in chronic pulmonary disease. Respirology, 2007, 12, 634-641. (Pubitemid 47414891)
Iribarren C, Tolstykh IV, Eisner MD. - Are patients with asthma at risk for coronary heart disease. Int J Epidemiol, 2004, 33, 743-748. (Pubitemid 39263849)
Gottlieb SS, McCarter RJ, Vogel RA. - Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Eng J Med, 1998, 339, 489-497. (Pubitemid 28384881)
Chen J, Radford MJ, Wang Y, et al. - Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol, 2001, 37, 1950-1956. (Pubitemid 32499985)
Ollivier R, Donal E, Delaval P, et al. - Prescription des bétabloquants et broncho-pneumopathie chronique obstructive. Ann Cardiol Angéiol, 2007, 56, 231-236. (Pubitemid 350007415)
Van Gestel Y, Hoeks SE, Sin DD, et al. - Impact of cardioselective β-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med, 2008, 178, 695-700.
Mascarenhas J, Lourenço P, Lopes R, et al. - Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. Am Heart J, 2008, 155, 521-525. (Pubitemid 351255605)
Kotlyar E, Keogh AM, McDonald PS, et al. - Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant, 2002, 21, 1290-1295. (Pubitemid 35477743)
Jabbour A, McDonald PS, Keogh AM, et al. - Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease. Am J Coll Cardiol, 2010, 55, 1780-1787.
Dart RA, Gollub S, Lazar J, et al. - Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma. Chest, 2003, 123, 222-243. (Pubitemid 36126736)
Salpeter SR, Ormiston TM, Salpeter EE. - Cardioselective β-blockers in patients with reactive airway disease : a meta-analysis. Ann Intern Med, 2002, 137, 715-725. (Pubitemid 35265315)
Salpeter S, Ormiston T, Salpeter E. - Cardioselective beta-blockers for chronic obstructive pulmonary diseas. Cochrane Database Syst Rev, 2005, Issue 4. Art No. CD003566
Ashrafian H, Violaris AG. - Beta-blocker therapy of cardiovascular diseases in patients with bronchial asthma or COPD : the pro viewpoint. Primary Care Respir J, 2005, 14, 236-241. (Pubitemid 41436408)
Lipworth BJ, Williamson PA. - β-blockers for asthma : a double edged sword. Lancet, 2009, 373, 104-105.
Dransfield MT, Rowe SM, Johnson JE, et al.- Use of β-blockers and the risk of death in hospitalised patients with acute exacerbation of COPD. Thorax, 2008, 63, 301-305. (Pubitemid 351497940)
